CXCL8 and lung cancer: IL-8 induces MAPK/ERK signaling and promotes lung cancer proliferation and metastasis [49] as well as colorectal cancer (CRC) cell proliferation, migration and angiogenesis, and thus is also a therapeutic target [50].